Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 8/20 | 0.44 |
| ▸ | CA2 | P00918 | 8/20 | 0.44 |
| ▸ | CA9 | Q16790 | 7/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1572937 | 1.00 | DNM1 (0.55) | DNM1HTTKMT2ACA1CA2 | |
| SCHEMBL6858953 | 1.00 | DNM1 (0.55) | DNM1HTTKMT2ACA1CA2 | |
| SCHEMBL8885118 | 1.00 | DNM1 (0.55) | DNM1HTTKMT2ACA1CA2 | |
| Hydrochloric Acid SCHEMBL8961957 | 0.98 | DNM1 (0.53) | DNM1HTTKMT2ACA1CA2 | |
| Water SCHEMBL2687246 | 0.98 | DNM1 (0.53) | DNM1HTTKMT2ACA1CA2 | |
| Hydrochloric Acid SCHEMBL8962131 | 0.98 | DNM1 (0.53) | DNM1HTTKMT2ACA1CA2 | |
| Water SCHEMBL2025641 | 0.98 | DNM1 (0.53) | DNM1HTTKMT2ACA1CA2 | |
| Bromide SCHEMBL10492709 | 0.98 | DNM1 (0.57) | DNM1HTTKMT2ACA1CA2 | |
| SCHEMBL8436911 | 0.96 | DNM1 (0.55) | DNM1HTTCA1CA2CA9 | |
| SCHEMBL8884394 | 0.96 | DNM1 (0.55) | DNM1HTTCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6989195-B2 | Coated particles, methods of making and using | LYOTROPIC THERAPEUTICS, INC. (US) | 2006-01-24 | — | — | US | claimed |
| US-20040201117-A1 | COATED PARTICLES, METHODS OF MAKING AND USING | ANDERSON DAVID (US) | 2004-10-14 | — | — | US | claimed |
| US-20210015796-A1 | TREATMENT USING DANTROLENE | LYOTROPIC THERAPEUTICS INC (US) | 2021-01-21 | — | — | US | disclosed |
| EP-1603513-B1 | DANTROLENE COMPOSITIONS | LYOTROPIC THERAPEUTICS INC (US) | 2020-12-30 | — | — | EP | disclosed |
| US-10821098-B2 | Treatment using dantrolene | LYOTROPIC THERAPEUTICS, INC. (US) | 2020-11-03 | — | — | US | disclosed |
| US-10597298-B2 | Ceramic encapsulation by use of one or more specialized silanes to template oil in an oil in water emulsion | CoLabs International Corporation (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190255021-A1 | TREATMENT USING DANTROLENE | LYOTROPIC THERAPEUTICS INC (US) | 2019-08-22 | — | — | US | disclosed |
| US-10314822-B2 | Treatment using dantrolene | LYOTROPIC THERAPEUTICS, INC. (US) | 2019-06-11 | — | — | US | disclosed |
| US-20180125822-A1 | TREATMENT USING DANTROLENE | LYOTROPIC THERAPEUTICS INC (US) | 2018-05-10 | — | — | US | disclosed |
| US-20180037464-A1 | Ceramic Encapsulation by Use of One or More Specialized Silanes to Template Oil in an Oil in Water Emulsion | CoLabs International Corporation (US) | 2018-02-08 | — | — | US | disclosed |
| US-9884044-B2 | Treatment using dantrolene | LYOTROPIC THERAPEUTICS, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| EP-0942780-A4 | COATED PARTICLES, METHODS OF MAKING AND USING | SELECT RELEASE L C (US) | 2001-01-10 | — | — | EP | disclosed |
| US-6004771-A | EXTRACTED MYCOBACTERIAL SAMPLE IS SUITABLE FOR DETECTION BY CULTURE AND AMPLIFICATION | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0942780-A1 | COATED PARTICLES, METHODS OF MAKING AND USING | Select Release, L.C. (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1999012640-A1 | COATED PARTICLES, METHODS OF MAKING AND USING | SELECT RELEASE, L.C. (US) | 1999-03-18 | — | — | WO | disclosed |
| US-5880076-A | PERSONAL PRODUCT OR DETERGENT COMPOSITION COMPRISING CYCLIC GLYCACARBAMATE AND/OR GLYCAUREA, SURFACTANT | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1999-03-09 | — | — | US | disclosed |
| US-5658749-A | DECREASING THE BUOYANCY OF MICROORGANISMS CONTAINING MYCOLIC ACID-LIKE STRUCTURES IN THE OUTER MEMBRANE USING A SOLUTION OF AN SB-18-LIKE OR ROD-LIKE DETERGENT; AMPHOTERIC SURFACTANTS; MEDICAL DIAGNOSIS; CULTURES; AMPLIFICATION | CORNING CLINICAL LABORATORIES, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5653970-A | CLEANING COMPOUNDS; COSMETICS | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-08-05 | — | — | US | disclosed |
| US-5641480-A | ENHANCED STABILITY AND/OR VISCOSITY, CLARITY | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-06-24 | — | — | US | disclosed |
| US-5624906-A | Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-04-29 | — | — | US | disclosed |